[go: up one dir, main page]

ITRM910189A0 - Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono - Google Patents

Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono

Info

Publication number
ITRM910189A0
ITRM910189A0 IT91RM189A ITRM910189A ITRM910189A0 IT RM910189 A0 ITRM910189 A0 IT RM910189A0 IT 91RM189 A IT91RM189 A IT 91RM189A IT RM910189 A ITRM910189 A IT RM910189A IT RM910189 A0 ITRM910189 A0 IT RM910189A0
Authority
IT
Italy
Prior art keywords
aminoacil
allopurinol
contain
pharmaceutical compositions
immunostimulant activity
Prior art date
Application number
IT91RM189A
Other languages
English (en)
Inventor
Mauro Marzi
Patrizia Minetti
Piero Foresta
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM910189A0 publication Critical patent/ITRM910189A0/it
Priority to ITRM910189A priority Critical patent/IT1244501B/it
Priority to ES92830136T priority patent/ES2094335T3/es
Priority to AT92830136T priority patent/ATE143024T1/de
Priority to DE69213794T priority patent/DE69213794T2/de
Priority to DK92830136.5T priority patent/DK0506628T3/da
Priority to EP92830136A priority patent/EP0506628B1/en
Priority to US07/854,916 priority patent/US5272151A/en
Priority to JP4065009A priority patent/JP3067886B2/ja
Publication of ITRM910189A1 publication Critical patent/ITRM910189A1/it
Application granted granted Critical
Publication of IT1244501B publication Critical patent/IT1244501B/it
Priority to GR960402931T priority patent/GR3021556T3/el
Priority to HK98105617A priority patent/HK1006462A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ITRM910189A 1991-03-22 1991-03-22 Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono IT1244501B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITRM910189A IT1244501B (it) 1991-03-22 1991-03-22 Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
DK92830136.5T DK0506628T3 (da) 1991-03-22 1992-03-20 Aminoacyl- og oligopeptidylderivater af allopurinol, der udviser immunostimulerende aktivitet, og farmaceutiske formuleringer indeholdende disse stoffer
AT92830136T ATE143024T1 (de) 1991-03-22 1992-03-20 Aminoacyl und oligopeptidylderivate von allopurinol mit immunostimulierender wirkung und diese enthaltende pharmazeutische zubereitungen
DE69213794T DE69213794T2 (de) 1991-03-22 1992-03-20 Aminoacyl und Oligopeptidylderivate von Allopurinol mit immunostimulierender Wirkung und diese enthaltende pharmazeutische Zubereitungen
ES92830136T ES2094335T3 (es) 1991-03-22 1992-03-20 Derivados de alopurinol aminoacilados y oligopeptidos de actividad inmunoestimuladora y composiciones farmaceuticas que los contienen.
EP92830136A EP0506628B1 (en) 1991-03-22 1992-03-20 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
US07/854,916 US5272151A (en) 1991-03-22 1992-03-20 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
JP4065009A JP3067886B2 (ja) 1991-03-22 1992-03-23 アロプリノール誘導体および医薬製剤
GR960402931T GR3021556T3 (en) 1991-03-22 1996-11-06 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
HK98105617A HK1006462A1 (en) 1991-03-22 1998-06-18 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity and pharma-ceutical formulations containing these substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910189A IT1244501B (it) 1991-03-22 1991-03-22 Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITRM910189A0 true ITRM910189A0 (it) 1991-03-22
ITRM910189A1 ITRM910189A1 (it) 1992-09-22
IT1244501B IT1244501B (it) 1994-07-15

Family

ID=11399991

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910189A IT1244501B (it) 1991-03-22 1991-03-22 Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono

Country Status (10)

Country Link
US (1) US5272151A (it)
EP (1) EP0506628B1 (it)
JP (1) JP3067886B2 (it)
AT (1) ATE143024T1 (it)
DE (1) DE69213794T2 (it)
DK (1) DK0506628T3 (it)
ES (1) ES2094335T3 (it)
GR (1) GR3021556T3 (it)
HK (1) HK1006462A1 (it)
IT (1) IT1244501B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928191A (en) * 1993-07-30 1999-07-27 E.P. Technologies, Inc. Variable curve electrophysiology catheter
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
US6191136B1 (en) 1997-11-07 2001-02-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
DE69924651D1 (de) 1998-08-12 2005-05-12 Gilead Sciences Inc Verfahren zu Herstellung von 1,3-Oxathiolane Nukleosiden
CN1503796B (zh) 2001-03-01 2012-07-04 三角药品公司 顺-ftc的多晶型物及其它晶型
BR0214940A (pt) * 2001-12-14 2006-05-30 Pharmasset Ltd preparação de intermediários úteis na sìntese de nucleosìdeos antivirais
DE60335805D1 (de) 2002-08-06 2011-03-03 Pharmasset Inc Verfahren zur herstellung von 1,3-dioxolan-nucleosiden
US6953041B2 (en) 2002-10-09 2005-10-11 Micell Technologies, Inc. Compositions of transition metal species in dense phase carbon dioxide and methods of use thereof
WO2005066694A2 (en) 2003-12-29 2005-07-21 Advanced Medical Optics, Inc. Intraocular lenses having a visible light-selective-transmissive-region
US7067659B2 (en) * 2004-04-23 2006-06-27 Duke University Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
EP2574976B1 (en) 2004-04-30 2021-08-11 Johnson & Johnson Surgical Vision, Inc. Ophthalmic devices having a highly selective violet light transmissive filter
WO2006057824A2 (en) * 2004-11-22 2006-06-01 Advanced Medical Optics, Inc. Copolymerizable methine and anthraquinone compounds and articles containing them
WO2006057840A2 (en) * 2004-11-22 2006-06-01 Advanced Medical Optics, Inc. Copolymerizable azo compounds and articles containing them
US8188098B2 (en) * 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
EP3915565A3 (en) * 2013-03-15 2022-03-16 XORTX Therapeutics Inc. Xanthine oxidase inhibitor formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165520A (en) * 1965-01-12 Certificate of correction
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US4602089A (en) * 1982-03-12 1986-07-22 Newport Pharmaceuticals, Inc. Process for preparing purine compounds
DK302883D0 (da) * 1983-06-30 1983-06-30 Hans Bundgaard Allopurinol prodrugs
US4663326A (en) * 1985-04-04 1987-05-05 Warner-Lambert Company Pyrazolo[4,3-d]pyrimidine-5,7-(4H,6H)dione or -5-thione-7-one analogs
JP2528684B2 (ja) * 1986-08-11 1996-08-28 ヘマサイエンス、ラボラトリーズ、インコーポレイテッド 特に使い捨て連続流血液ロ過システムカ―トリッジに適したゆるいアイレットを備えたピボットピンベアリング/シ―ル
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina

Also Published As

Publication number Publication date
ES2094335T3 (es) 1997-01-16
DE69213794T2 (de) 1997-02-06
DE69213794D1 (de) 1996-10-24
GR3021556T3 (en) 1997-02-28
HK1006462A1 (en) 1999-02-26
EP0506628A3 (en) 1992-10-21
DK0506628T3 (da) 1996-11-11
JP3067886B2 (ja) 2000-07-24
ATE143024T1 (de) 1996-10-15
EP0506628B1 (en) 1996-09-18
ITRM910189A1 (it) 1992-09-22
JPH05117275A (ja) 1993-05-14
US5272151A (en) 1993-12-21
IT1244501B (it) 1994-07-15
EP0506628A2 (en) 1992-09-30

Similar Documents

Publication Publication Date Title
BR1100824A (pt) Composto e composição farmacêutica
FR2636532B1 (fr) Compositions pharmaceutiques
IT9022032A0 (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
ITRM910189A0 (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
KR930701456A (ko) 세팔로스포린 및 동족체, 제조 및 제약학적 조성물
BR9200058A (pt) Composto e composicao farmaceutica
IT8947546A0 (it) Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
IT1227899B (it) Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
ITMI912237A0 (it) Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono
IT8149623A0 (it) Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
IT9048102A0 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
BR8905444A (pt) Composicoes e aplicacao
IT1231342B (it) Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
IT8103423A0 (it) Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono
ITRM920760A0 (it) Derivati amminoacilici e oligopeptidici dell'ipoxantina b-sostituita dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono.
ITRM910829A0 (it) Derivati dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
BR9205599A (pt) Derivados de ácido carbamico alquiltioetanamina e seu uso em composiçoes biocidas
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
IT1227892B (it) Composizioni farmaceutiche ad attivita' antidepressiva e ansiolitica
BR1100393A (pt) Composto e formulação farmacêutica
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950131